Plainsboro, NJ, United States of America

Hyei-Jha Chung

This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyei-Jha Chung. Retrieved from https://idiyas.com/inventor/hyei-jha-chung

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hyei-Jha Chung: Innovator in Pharmaceutical Chemistry

Introduction

Hyei-Jha Chung is a notable inventor based in Plainsboro, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds.

Latest Patents

Hyei-Jha Chung holds 1 patent for his work on "Fused pyridopyridazine inhibitors of cGMP phosphodiesterase - Compounds of the formula." This patent reflects his expertise in creating compounds that have potential therapeutic applications.

Career Highlights

Chung is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work at Bristol-Myers Squibb has allowed him to engage in cutting-edge research and development in the pharmaceutical industry.

Collaborations

Throughout his career, Hyei-Jha Chung has collaborated with talented colleagues, including Michael J. Humora and Kishta Katipally. These collaborations have fostered a productive environment for innovation and discovery.

Conclusion

Hyei-Jha Chung's contributions to pharmaceutical chemistry and his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…